In line with our findings, a meta-analysis based on the 37 studies reported increased CD133 expression in CRC as a poor prognostic factor in CRC patients and it was positively correlated with lymphatic and vascular invasion, distant metastasis, and tumor T category (47). Here, PROM1 is linked to colorectal carcinoma.